Related Experiment Video

Updated: Jun 18, 2026

Brain Slice Biotinylation: An Ex Vivo Approach to Measure Region-specific Plasma Membrane Protein Trafficking in Adult Neurons
06:18

Brain Slice Biotinylation: An Ex Vivo Approach to Measure Region-specific Plasma Membrane Protein Trafficking in Adult Neurons

Published on: April 3, 2014

Resistance of the dopamine D4 receptor to agonist-induced internalization and degradation

Anneleen Spooren1, Pieter Rondou, Katarzyna Debowska

  • 1Laboratory of Eukaryotic Gene Expression and Signal Transduction (LEGEST), Ghent University-UGent, K.L. Ledeganckstraat 35, B-9000 Gent, Belgium.

Cellular Signalling
|November 26, 2009
PubMed

Insights

The human dopamine D4 receptor resists signal attenuation after agonist stimulation. This resistance to phosphorylation, internalization, and degradation impacts cellular response and homeostasis.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Dopamine receptors (GPCRs) regulate critical brain functions.
  • GPCRs typically desensitize, internalize, and down-regulate upon stimulation.
  • These processes restore cellular homeostasis and prevent overstimulation.

Purpose of the Study:

  • To investigate agonist-mediated signal attenuation of the dopamine D4 receptor.
  • To determine if the D4 receptor undergoes typical desensitization pathways.

Main Methods:

  • Investigated receptor phosphorylation, internalization, and degradation.
  • Assessed beta-arrestin recruitment upon D4 receptor stimulation.
  • Examined D4 receptor behavior in various cell lines (CHO, HeLa, HEK293, HT22) and primary neurons.

Main Results:

  • Dopamine D4 receptor showed blunted responses in phosphorylation, internalization, and degradation.
  • No beta-arrestin recruitment was observed upon D4 receptor stimulation.
  • Constitutive phosphorylation of serine residues in the third intracellular loop was identified.
  • D4 receptor demonstrated resistance to agonist-mediated internalization and down-regulation in multiple cell types.

Conclusions:

  • The human dopamine D4 receptor exhibits significant resistance to agonist-mediated signal attenuation.
  • This unique property may influence its role in neurological processes and drug development.
  • Further research is needed to understand the implications of D4 receptor attenuation resistance.

More Related Videos

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake11:26

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake

Published on: September 21, 2017

Related Concept Videos

Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.